Metrion Biosciences Ltd
Metrion Biosciences Ltd, a leading contract research organisation based in Great Britain, specialises in ion channel drug discovery and safety pharmacology. Founded in 2013, the company has rapidly established itself as a key player in the biotechnology sector, providing innovative solutions to pharmaceutical and biotech clients. With headquarters in Cambridge and operational reach across Europe and North America, Metrion offers a unique suite of services, including bespoke ion channel screening and advanced electrophysiology. Their commitment to scientific excellence and customer-focused approach has garnered recognition within the industry, positioning them as a trusted partner for drug development. Metrion's state-of-the-art technology and expertise in ion channel pharmacology set them apart, making significant contributions to the advancement of therapeutic research.
DitchCarbon Score
How does Metrion Biosciences Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Metrion Biosciences Ltd's score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Metrion Biosciences Ltd's reported carbon emissions
Metrion Biosciences Ltd, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Metrion Biosciences Ltd appears to be in the early stages of establishing its climate commitments and emissions reporting. Without specific emissions data or reduction initiatives, it is unclear how the company plans to address its carbon footprint or contribute to broader climate goals. In the context of the biotechnology industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. Metrion Biosciences Ltd may benefit from aligning with industry standards and best practices to enhance its climate strategy in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Metrion Biosciences Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
